These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11315872)

  • 1. Outcome of fetuses with increased nuchal translucency.
    Bilardo CM; Müller MA; Pajkrt E
    Curr Opin Obstet Gynecol; 2001 Apr; 13(2):169-74. PubMed ID: 11315872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
    Devine PC; Malone FD
    Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of fetal nuchal translucency.
    Jackson M; Rose NC
    Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.
    Bilardo CM; Müller MA; Zikulnig L; Schipper M; Hecher K
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):288-94. PubMed ID: 11339183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
    Brady AF; Pandya PP; Yuksel B; Greenough A; Patton MA; Nicolaides KH
    J Med Genet; 1998 Mar; 35(3):222-4. PubMed ID: 9541107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal nuchal translucency thickness at 10-14 weeks' gestation and congenital diaphragmatic hernia.
    Sebire NJ; Snijders RJ; Davenport M; Greenough A; Nicolaides KH
    Obstet Gynecol; 1997 Dec; 90(6):943-6. PubMed ID: 9397108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
    Souka AP; Snijders RJ; Novakov A; Soares W; Nicolaides KH
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):391-400. PubMed ID: 9674084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination.
    Josefsson A; Molander E; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
    Horner E; Holzgreve W; Batucan C; Tercanli S
    Praxis (Bern 1994); 2002 Feb; 91(7):261-5. PubMed ID: 11883361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
    Hyett J; Perdu M; Sharland G; Snijders R; Nicolaides KH
    BMJ; 1999 Jan; 318(7176):81-5. PubMed ID: 9880278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
    Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
    BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does nuchal translucency have a role in fetal cardiac screening?
    Hyett J
    Prenat Diagn; 2004 Dec; 24(13):1130-5. PubMed ID: 15614845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.